Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -33 | -6 | 13 | 1 | 12 |
| Other Working Capital | 226 | 49 | 75 | 394 | 137 |
| Other Operating Activity | -201 | -186 | -94 | -469 | -367 |
| Operating Cash Flow | $-8 | $-142 | $-6 | $-74 | $-218 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | -26 | 65 | 0 |
| Common Stock Issued | 0 | 149 | 0 | N/A | N/A |
| Financing Cash Flow | $0 | $149 | $-26 | $65 | $0 |
| Beginning Cash Position | 21 | 15 | 46 | 55 | 273 |
| End Cash Position | 13 | 21 | 15 | 46 | 55 |
| Net Cash Flow | $-8 | $6 | $-32 | $-9 | $-218 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8 | -142 | -6 | -74 | -218 |
| Free Cash Flow | -8 | -142 | -6 | -74 | -218 |